PT1147115E - Benzodiazepinas triciclicas como antagonistas do receptor da vasopressina - Google Patents

Benzodiazepinas triciclicas como antagonistas do receptor da vasopressina

Info

Publication number
PT1147115E
PT1147115E PT99966495T PT99966495T PT1147115E PT 1147115 E PT1147115 E PT 1147115E PT 99966495 T PT99966495 T PT 99966495T PT 99966495 T PT99966495 T PT 99966495T PT 1147115 E PT1147115 E PT 1147115E
Authority
PT
Portugal
Prior art keywords
benzodiazepins
tricycle
receptor antagonists
vasopressin receptor
vasopressin
Prior art date
Application number
PT99966495T
Other languages
English (en)
Inventor
Bruce E Maryanoff
William Hoekstra
Alexey B Dyatkin
Jay M Matthews
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of PT1147115E publication Critical patent/PT1147115E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
PT99966495T 1999-01-19 1999-12-21 Benzodiazepinas triciclicas como antagonistas do receptor da vasopressina PT1147115E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11635899P 1999-01-19 1999-01-19
US46865099A 1999-12-21 1999-12-21

Publications (1)

Publication Number Publication Date
PT1147115E true PT1147115E (pt) 2004-02-27

Family

ID=26814157

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99966495T PT1147115E (pt) 1999-01-19 1999-12-21 Benzodiazepinas triciclicas como antagonistas do receptor da vasopressina

Country Status (27)

Country Link
US (2) US6713475B2 (pt)
EP (1) EP1147115B3 (pt)
KR (1) KR100771184B1 (pt)
CN (1) CN1174986C (pt)
AR (1) AR035837A1 (pt)
AT (1) ATE249465T1 (pt)
AU (1) AU772397B2 (pt)
BR (1) BRPI9917086B8 (pt)
CA (1) CA2360767C (pt)
CZ (1) CZ302647B6 (pt)
DE (2) DE69911259T4 (pt)
DK (1) DK1147115T5 (pt)
ES (1) ES2207333T7 (pt)
HK (1) HK1038361B (pt)
HU (1) HU229074B1 (pt)
IL (2) IL144270A0 (pt)
ME (1) ME00129B (pt)
MY (1) MY128065A (pt)
NO (1) NO327896B1 (pt)
NZ (1) NZ512960A (pt)
PL (1) PL205704B1 (pt)
PT (1) PT1147115E (pt)
RS (1) RS50820B (pt)
TR (1) TR200102069T2 (pt)
TW (1) TWI289564B (pt)
UA (1) UA70984C2 (pt)
WO (1) WO2000043398A2 (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ME00129B (me) * 1999-01-19 2010-10-10 Ortho Mcneil Janssen Pharmaceuticals Inc Triciklicnj benzodiazepini kao antagonisti receptora vazopresina
ES2288899T3 (es) * 2000-10-04 2008-02-01 Astellas Pharma Inc. Uso de un antagonista de vasopresina tal como conivaptan en la fabricacion de un medicamento para el tratamiento de la hipertension pulmonar.
ES2282423T3 (es) 2001-04-12 2007-10-16 Wyeth Azepinas y diazepinas bi- y triciclicas n-bifenilcarbonil- y n-fenilpiridilcarbonil sustituidas como agonistas de la vasopresina.
DK1381608T3 (da) 2001-04-12 2008-02-04 Wyeth Corp Cyclohexylphenylvasopressinagonister
ES2287326T3 (es) * 2001-10-29 2007-12-16 Ortho-Mcneil Pharmaceutical, Inc. Antagonistas del receptor de vasopresina de (,4) benzodiazepina biciclica enlazada.
EP1364968A1 (en) * 2002-05-23 2003-11-26 Bayer Aktiengesellschaft Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 1 (AVPR1)
US7119088B2 (en) 2003-02-19 2006-10-10 Pfizer Inc. Triazole compounds useful in therapy
GB0303852D0 (en) * 2003-02-19 2003-03-26 Pfizer Ltd Triazole compounds useful in therapy
GEP20074089B (en) * 2003-02-19 2007-04-10 Pfizer Triazole compounds useful in therapy
JP2008518915A (ja) 2004-10-28 2008-06-05 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ バソプレシンv2受容体アンタゴニストとしての新規な[1,4]ベンゾジアゼピン
DE102005003632A1 (de) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Katheter für die transvaskuläre Implantation von Herzklappenprothesen
US20070213813A1 (en) 2005-12-22 2007-09-13 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US20090318412A1 (en) * 2006-07-11 2009-12-24 Takahiro Matsumoto Tricyclic heterocyclic compound and use thereof
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
BR112012021347A2 (pt) 2008-02-26 2019-09-24 Jenavalve Tecnology Inc stent para posicionamento e ancoragem de uma prótese valvular em um local de implantação no coração de um paciente
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
KR101348499B1 (ko) * 2008-11-13 2014-01-06 에프. 호프만-라 로슈 아게 스피로-5,6-다이하이드로-4h-2,3,5,10b-테트라아자-벤조〔e〕아줄렌
SI2358714T1 (sl) * 2008-11-18 2012-11-30 Hoffmann La Roche Alkilcikloheksiletri dihidrotetraazabenzoazulenov
NZ592076A (en) * 2008-11-28 2012-06-29 Hoffmann La Roche Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin via receptor antagonists
DE102009033392A1 (de) * 2009-07-16 2011-01-20 Merck Patent Gmbh Heterocyclische Verbindungen als Autotaxin-Inhibitoren II
WO2011036204A1 (en) * 2009-09-24 2011-03-31 Shire-Movetis N.V. [1,4]-benzodiazepines as vasopressin v2 receptor antagonists
US8420633B2 (en) 2010-03-31 2013-04-16 Hoffmann-La Roche Inc. Aryl-cyclohexyl-tetraazabenzo[e]azulenes
US8461151B2 (en) 2010-04-13 2013-06-11 Hoffmann-La Roche Inc. Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes
US8492376B2 (en) 2010-04-21 2013-07-23 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
US8481528B2 (en) 2010-04-26 2013-07-09 Hoffmann-La Roche Inc. Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
US8513238B2 (en) 2010-05-10 2013-08-20 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes
BR112012029896A2 (pt) 2010-05-25 2017-06-20 Jenavalve Tech Inc válcula cardíaca protética para endoprótese e endoprótese
US8828989B2 (en) 2011-09-26 2014-09-09 Hoffmann-La Roche Inc. Oxy-cyclohexyl-4H,6H-5-oxa-2,3,10b-triaza-benzo[E]azulenes as V1A antagonists
EP4098226A1 (en) 2013-08-30 2022-12-07 JenaValve Technology, Inc. Endoprosthesis comprising a radially collapsible frame and a prosthetic valve
WO2016089833A1 (en) * 2014-12-05 2016-06-09 Merck Sharp & Dohme Corp. Novel tricyclic compounds as inhibitors of mutant idh enzymes
WO2016089830A1 (en) * 2014-12-05 2016-06-09 Merck Sharp & Dohme Corp. Novel tricyclic compounds as inhibitors of mutant idh enzymes
EP3226688B1 (en) 2014-12-05 2020-07-01 Merck Sharp & Dohme Corp. Tricyclic compounds as inhibitors of mutant idh enzymes
WO2016177562A1 (en) 2015-05-01 2016-11-10 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
CN109475419B (zh) 2016-05-13 2021-11-09 耶拿阀门科技股份有限公司 用于通过引导鞘和装载系统来递送心脏瓣膜假体的心脏瓣膜假体递送系统和方法
WO2018138658A1 (en) 2017-01-27 2018-08-02 Jenavalve Technology, Inc. Heart valve mimicry
EP3875078A1 (en) * 2020-03-06 2021-09-08 Dompe' Farmaceutici S.P.A. Compounds for the treatment of covid-19

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732212A (en) 1970-04-20 1973-05-08 Sterling Drug Inc 1,2,3,10,11,11a-hexahydro-5h-pyrrolo(2,1-c)(1,4)benzodiazepine-5,11-diones
US3763183A (en) * 1972-07-10 1973-10-02 Sterling Drug Inc 1,2,3,10,11,11a-hexahydro-5h-pyrrolo (2,1-c)(1,4)benzodiazepines
US3860600A (en) 1972-07-10 1975-01-14 Sterling Drug Inc Octahydropyrrido{8 2,1-c{9 {8 1,4{9 benzodiazepines
US5516774A (en) * 1993-07-29 1996-05-14 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
US5521173A (en) * 1995-01-17 1996-05-28 American Home Products Corporation Tricyclic benzazepine vasopressin antagonists
CA2285343A1 (en) * 1997-03-31 1998-10-08 Wakamoto Pharmaceutical Co., Ltd. Biphenyl derivatives and medicinal compositions
WO1999006409A1 (en) * 1997-07-30 1999-02-11 American Home Products Corporation Tricyclic vasopressin agonists
ME00129B (me) * 1999-01-19 2010-10-10 Ortho Mcneil Janssen Pharmaceuticals Inc Triciklicnj benzodiazepini kao antagonisti receptora vazopresina

Also Published As

Publication number Publication date
AU772397B2 (en) 2004-04-29
CZ302647B6 (cs) 2011-08-17
US20020103373A1 (en) 2002-08-01
DE69911259T2 (de) 2004-12-02
NO327896B1 (no) 2009-10-12
DE69911259T4 (de) 2009-07-09
HK1038361B (zh) 2004-05-07
HUP0105034A3 (en) 2004-11-29
EP1147115B3 (en) 2008-12-24
CN1174986C (zh) 2004-11-10
US6713475B2 (en) 2004-03-30
YU51901A (sh) 2004-03-12
ATE249465T1 (de) 2003-09-15
MY128065A (en) 2007-01-31
AR035837A1 (es) 2004-07-21
PL205704B1 (pl) 2010-05-31
NO20013515D0 (no) 2001-07-16
BRPI9917086B8 (pt) 2016-05-24
US7317005B2 (en) 2008-01-08
DE69911259D1 (de) 2003-10-16
TR200102069T2 (tr) 2001-11-21
EP1147115B1 (en) 2003-09-10
ES2207333T7 (es) 2009-06-18
UA70984C2 (uk) 2004-11-15
US20040242866A1 (en) 2004-12-02
AU2201400A (en) 2000-08-07
ES2207333T3 (es) 2004-05-16
MEP17808A (en) 2010-06-10
CZ20012598A3 (cs) 2002-08-14
HU229074B1 (en) 2013-07-29
ME00129B (me) 2010-10-10
HUP0105034A2 (hu) 2002-04-29
NO20013515L (no) 2001-09-17
CA2360767C (en) 2009-11-03
KR20010101577A (ko) 2001-11-14
RS50820B (sr) 2010-08-31
WO2000043398A2 (en) 2000-07-27
DK1147115T5 (da) 2008-12-08
KR100771184B1 (ko) 2007-10-29
EP1147115A2 (en) 2001-10-24
PL349778A1 (en) 2002-09-09
IL144270A (en) 2010-04-29
BR9917086A (pt) 2001-10-30
CN1339038A (zh) 2002-03-06
IL144270A0 (en) 2002-05-23
HK1038361A1 (en) 2002-03-15
WO2000043398A3 (en) 2001-01-11
AU772397C (en) 2000-08-07
CA2360767A1 (en) 2000-07-27
BR9917086B1 (pt) 2013-12-03
TWI289564B (en) 2007-11-11
NZ512960A (en) 2004-01-30
DK1147115T3 (da) 2004-01-12

Similar Documents

Publication Publication Date Title
PT1147115E (pt) Benzodiazepinas triciclicas como antagonistas do receptor da vasopressina
PT1224175E (pt) Derivados de benzodiazepina como antagonistas do receptor de glutamato metabotropico
CY2010003I2 (el) Αγωνιστες των βητα-2 αδρενεργικων υποδοχεων
DE60026169D1 (de) Selektive neurokinin-antagonisten
PT1444215E (pt) Derivados de 1,2,4-triadiazolio como moduladores do receptor de melanocortina
ATE246127T1 (de) Kompositverschlusskappe
ATE281983T1 (de) Kompositverschlusskappe
NO20015779L (no) Bradykinin-reseptorantagonister
PT1226131E (pt) Derivados de isoxazolecarboxamida como antagonistas do receptor adrenergico alfa1
BR9607153A (pt) Derivados de benzazepina bicíclicos como antagonistas de vasopressina
NO20013997D0 (no) Reseptoranalyse
PT1027342E (pt) Derivados de ciclopentenos uteis como antagonistas do receptor da motilina
NO20016053L (no) IL-8 reseptor-antagonister
ATE286022T1 (de) Naphthalin-carboxamide als tachykinin rezeptorantagonisten
EP1248607A4 (en) UROTENSIN II RECEPTOR ANTAGONISTS
PT1171419E (pt) Derivados de bifenilo como antagonistas do receptor da neuroquinina-1
PT964863E (pt) Oxazolidinonas como antagonistas de 5-ht2a
PT1176144E (pt) Novos derivados de n-triazolilmetil piperazina como antagonistas do receptor da neuroquinina
BR9709982A (pt) Derivados de indolina úteis como antagonistas do receptor 5-ht-2c
DK1180028T3 (da) IL-8-receptorantagonister
DE60009931D1 (de) Muscarin-antagonisten
NO20015774D0 (no) IL-8 reseptorantagonister
NO20021295L (no) Nikotinsyreacetylcholin-reseptor
EP1809296A4 (en) NEW [1,4] -BENZODIAZEPINES AS VASOPRESSIN V2 RECEPTOR ANTAGONISTS
NO20016102D0 (no) IL-8 reseptorantagonister